ABOS Acumen Pharmaceuticals, Inc.

Fundamentals / CIK 0001576885 / USD

Acumen Pharmaceuticals, Inc. reported $85.56M in total assets and a net loss of $104.0M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ABOS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$0$0$0-$113.4MFY 2020 Net Income: -$7.33M2020FY 2021 Net Income: -$100.6M2021FY 2022 Net Income: -$42.86M2022FY 2023 Net Income: -$52.37M2023FY 2024 Net Income: -$102.3M2024FY 2025 Net Income: -$121.3M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $104.9M $93.80M $42.32M $32.36M $12.30M $8.00M
Total Operating Expenses $123.8M $114.0M $61.14M $45.24M $19.58M $9.35M
Operating Income -$123.8M -$114.0M -$61.14M -$45.24M -$19.58M -$7.91M
EBITDA -$123.8M -$114.0M -$61.08M -$45.20M -$19.58M --
Interest Income $7.45M $14.32M $10.79M $2.39M -- --
Interest Expense $4.22M $4.07M $581K $0 -- --
Income Tax Expense $0 $0 $0 $0 $0 $0
Net Income -$121.3M -$102.3M -$52.37M -$42.86M -$100.6M -$7.33M
Basic EPS -$2.00 -$1.71 -$1.08 -$1.06 -$5.02 -$26.05
Diluted EPS -$2.00 -$1.71 -$1.08 -$1.06 -$5.02 -$26.05
Basic Shares Outstanding 60.6M 60.0M 48.6M 40.6M 20.1M 281.2K
Diluted Shares Outstanding 60.6M 60.0M 48.6M 40.6M 20.1M 281.2K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $21.11M $27.81M $16.48M $20.53M $21.97M $37.12M $25.27M $34.57M
Total Operating Expenses $25.81M $32.56M $21.15M $25.20M $26.51M $41.75M $30.37M $39.60M
Operating Income -$25.81M -$32.56M -$21.15M -$25.20M -$26.51M -$41.75M -$30.37M -$39.60M
EBITDA -$25.80M -$32.55M -$21.14M -$25.19M -$26.50M -$41.73M -$30.36M -$39.58M
Interest Income $812K $1.11M $1.06M $1.32M $1.64M $2.02M $2.47M $2.99M
Interest Expense $999K $1.09M $1.07M $1.09M $1.07M $1.05M $1.02M $1.04M
Net Income -$25.37M -$32.72M -$20.74M -$25.14M -$26.45M -$40.95M -$28.80M -$37.15M
Basic EPS -$0.35 -$0.45 -$0.33 -- -$0.44 -$0.68 -$0.48 --
Diluted EPS -$0.35 -$0.45 -$0.33 -- -$0.44 -$0.68 -$0.48 --
Basic Shares Outstanding 72.3M 72.3M 63.2M -- 60.6M 60.6M 60.5M --
Diluted Shares Outstanding 72.3M 72.3M 63.2M -- 60.6M 60.6M 60.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $53.99M $35.63M $66.89M $130.1M $122.2M $43.78M
Short-Term Investments $62.88M $135.9M $176.6M $47.50M $72.08M --
Cash & Short-Term Investments $116.9M $171.6M $243.5M $177.6M $194.2M $43.78M
Other Current Assets -- -- $283K $237K $140K --
Total Current Assets $122.3M $178.3M $246.6M $180.3M $198.7M $44.43M
Property, Plant & Equipment, Net $103K $73K $122K $165K $36K --
Long-Term Investments $0 $59.97M $62.55M $15.84M $31.62M --
Other Non-Current Assets $350K $486K $724K $151K $14K $0
Total Non-Current Assets $581K $60.69M $63.51M $16.26M $31.67M $0
Total Assets $122.8M $239.0M $310.1M $196.6M $230.3M $44.43M
Accounts Payable $554K $5.65M $1.38M $1.64M $1.09M $531K
Short-Term Debt $8.77M $0 -- -- -- --
Other Current Liabilities -- -- $212K $131K $204K --
Total Current Liabilities $30.01M $27.61M $12.97M $7.81M $5.15M --
Long-Term Debt -- -- $29.90M $0 -- --
Other Non-Current Liabilities $0 $150K $284K -- -- --
Total Non-Current Liabilities $22.40M $29.57M $30.18M $0 $0 --
Total Liabilities $52.40M $57.18M $43.15M $7.81M $5.15M $6.37M
Total Debt (incl. Leases) $31.31M $29.70M $31.05M $105K -- --
Common Stock $6.0K $6.0K $6.0K $4.0K $4.0K --
Retained Earnings -$446.5M -$325.1M -$222.8M -$170.4M -$127.6M -$26.96M
Accumulated Other Comp. Income $83K -$48K $312K -$751K -- --
Total Stockholders' Equity $70.43M $181.8M $267.0M $188.8M $225.2M -$18.59M
Total Equity $70.43M $181.8M $267.0M $188.8M $225.2M -$18.59M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $53.08M $59.44M $51.80M $53.99M $46.83M $36.81M $30.16M $35.63M
Short-Term Investments $25.53M $50.75M $76.60M $62.88M $79.78M $106.6M $119.0M $135.9M
Cash & Short-Term Investments $78.60M $110.2M $128.4M $116.9M $126.6M $143.4M $149.1M $171.6M
Total Current Assets $85.13M $115.5M $133.1M $122.3M $132.2M $148.4M $154.9M $178.3M
Property, Plant & Equipment, Net $68K $80K $91K $103K $115K $130K $137K $73K
Long-Term Investments -- -- -- $0 $9.44M $22.80M $48.80M $59.97M
Other Non-Current Assets $200K $263K $304K $350K $393K $464K $504K $486K
Total Non-Current Assets $431K $494K $535K $581K $10.07M $23.49M $49.53M $60.69M
Total Assets $85.56M $116.0M $133.6M $122.8M $142.2M $171.9M $204.5M $239.0M
Accounts Payable $6.06M $13.38M $1.66M $554K $682K $2.10M $1.06M $5.65M
Short-Term Debt $20.40M $19.67M $14.12M $8.77M $3.60M -- -- $0
Total Current Liabilities $45.09M $46.85M $29.23M $30.01M $21.96M $24.86M $19.32M $27.61M
Long-Term Debt -- -- -- -- -- $29.88M $29.53M --
Other Non-Current Liabilities -- -- -- $0 $39K $77K $114K $150K
Total Non-Current Liabilities $5.87M $11.90M $16.92M $22.40M $27.09M $29.96M $29.64M $29.57M
Total Liabilities $50.95M $58.74M $46.15M $52.40M $49.05M $54.82M $48.96M $57.18M
Total Debt (incl. Leases) $26.31M $31.65M $31.16M $31.31M $30.84M $30.10M $29.78M $29.70M
Common Stock $7.0K $7.0K $7.0K $6.0K $6.0K $6.0K $6.0K $6.0K
Retained Earnings -$525.3M -$499.9M -$467.2M -$446.5M -$421.3M -$394.9M -$353.9M -$325.1M
Accumulated Other Comp. Income -$25K -$13K $21K $83K $109K $23K $15K -$48K
Total Stockholders' Equity $34.61M $57.26M $87.48M $70.43M $93.17M $117.1M $155.5M $181.8M
Total Equity $34.61M $57.26M $87.48M $70.43M $93.17M $117.1M $155.5M $181.8M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$121.3M -$102.3M -$52.37M -$42.86M -$100.6M -$7.33M
Depreciation & Amortization $58K $63K $61K $32K $4.0K --
Stock-Based Compensation $9.85M $9.63M $6.14M $3.06M $922K $154K
Change in Payables -$5.09M $4.27M -$261K $552K $557K $308K
Operating Cash Flow -$115.5M -$86.22M -$43.06M -$35.15M -$17.96M -$7.45M
Capital Expenditure -$88K -$16K -$21K -$161K -$40K --
Free Cash Flow -$115.6M -$86.23M -$43.09M -$35.31M -$18.00M --
Purchases of Investments -$38.06M -$170.7M -$250.6M -$41.51M -$104.1M --
Investing Cash Flow $133.9M $48.03M -$171.7M $39.19M -$104.1M --
Common Stock Issued $0 $7.94M $121.9M $3.79M $168.6M --
Financing Cash Flow -$34K $6.93M $151.8M $3.91M $200.5M $44.67M
Net Change in Cash $18.36M -$31.26M -$62.98M $7.94M $78.39M $37.23M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$25.37M -$32.72M -$20.74M -$25.14M -$26.45M -$40.95M -$28.80M -$37.15M
Depreciation & Amortization $12K $11K $12K $12K $15K $16K $15K $14K
Stock-Based Compensation $2.71M $2.52M $2.40M $2.42M $2.46M $2.50M $2.47M $2.34M
Change in Payables -$7.32M $11.78M $1.05M -$128K -$1.42M $1.05M -$4.59M $3.31M
Operating Cash Flow -$26.65M -$18.07M -$24.13M -$19.10M -$30.49M -$31.83M -$34.12M -$27.21M
Capital Expenditure $0 $0 $0 $0 $0 -$9.0K -$79K $0
Free Cash Flow -$26.65M -$18.07M -$24.13M -$19.10M -$30.49M -$31.84M -$34.20M -$27.21M
Purchases of Investments $0 $0 -$40.82M $0 $0 -$3.01M -$35.05M -$15.10M
Investing Cash Flow $25.25M $26.00M -$13.81M $26.25M $40.51M $38.48M $28.69M $29.66M
Common Stock Issued -- -- -- $0 $0 $0 $0 $0
Financing Cash Flow -$4.96M -$278K $35.74M $2.0K $0 $0 -$36K -$9.0K
Net Change in Cash -$6.37M $7.65M -$2.19M $7.16M $10.02M $6.65M -$5.47M $2.44M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -172.3% -56.3% -19.6% -22.7% -44.7% --
Return on Assets (ROA) -98.8% -42.8% -16.9% -21.8% -43.7% -16.5%
Current Ratio 4.07x 6.46x 19.01x 23.08x 38.60x --
Quick Ratio 3.90x 6.21x 18.77x 22.73x 37.74x --
Debt to Equity 0.44x 0.16x 0.12x 0.00x -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -300.4% -183.4% -129.5% -172.3% -143.1% -116.7% -74.8% -56.3%
Return on Assets (ROA) -121.5% -90.5% -84.8% -98.8% -93.8% -79.5% -56.9% -42.8%
Current Ratio 1.89x 2.47x 4.55x 4.07x 6.02x 5.97x 8.02x 6.46x
Quick Ratio 1.74x 2.35x 4.39x 3.90x 5.77x 5.77x 7.72x 6.21x
Debt to Equity 0.76x 0.55x 0.36x 0.44x 0.33x 0.26x 0.19x 0.16x
Source: SEC EDGAR CompanyFacts (CIK 0001576885) · from June 30, 2020 Data through September 30, 2026 · synced Nov 21, 2026, 05:04 UTC · Open in terminal